Developmental pharmacokinetics of gentamicin in preterm and term neonates: Population modelling of a prospective study

Clinical Pharmacokinetics

Volumn 48, Issue 4, 2009, Pages 253-263

  Nielsen, Elisabet I ^a,b   Sandström, Marie ^a,c   Honoré, Per Hartvig ^b,d   Ewald, Uwe ^e   Friberg, Lena E ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY CHILDREN S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; CREATININE; CYSTATIN C; GENTAMICIN; INDOMETACIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BODY WEIGHT; COMPARTMENT MODEL; COMPUTER PROGRAM; CONCENTRATION RESPONSE; DOSE TIME EFFECT RELATION; DRUG CLEARANCE; DRUG DOSE REGIMEN; GESTATIONAL AGE; HUMAN; INDIVIDUALIZATION; INFANT; KIDNEY FUNCTION; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; NEWBORN; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; ONSET AGE; POSTNATAL DEVELOPMENT; PREMATURITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SWEDEN;

EID: 66949146830     PISSN: 03125963     EISSN: 03125963     Source Type: Journal    
DOI: 10.2165/00003088-200948040-00003     Document Type: Article

References (55)

1. de Hoog M, van den Anker JN. Aminoglycosides and glycopeptides. In: Yaffe SJ, Aranda JV, editors. Neonatal and pediatric pharmacology, therapeutic principles in practice. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins, 2005: 377-401
2. Bastone EB, Li SC, Ioannides-Demos LL, et al. Kill kinetics and regrowth patterns of Escherichia coli exposed to gentamicin concentration-time profiles simulating in vivo bolus and infusion dosing. Antimicrob Agents Chemother 1993 Apr; 37 (4): 914-7
3. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987 Jan; 155 (1): 93-9
4. Begg EJ, Barclay ML. Aminoglycosides: 50 years on. Br J Clin Pharmacol 1995 Jun; 39 (6): 597-603
5. Kearns GL, Abdel-Rahman SM, Alander SW,etal. Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med 2003 Sep 18; 349 (12): 1157-67
6. Alcorn J, McNamara PJ. Pharmacokinetics in the newborn. Adv Drug Deliv Rev 2003 Apr 29; 55 (5): 667-86
7. Bartelink IH, Rademaker CM, Schobben AF, et al. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet 2006; 45 (11): 1077-97
8. van den Anker JN. Pharmacokinetics and renal function in preterm infants. Acta Paediatr 1996 Dec; 85 (12): 1393-9
9. van der Heijden AJ, Grose WF, Ambagtsheer JJ, et al. Glomerular filtration rate in the preterm infant: the relation to gestational and postnatal age. Eur J Pediatr 1988 Oct; 148 (1): 24-8
10. van den Anker JN, Hop WC, de Groot R, et al. Effects of prenatal exposure to betamethasone and indomethacin on the glomerular filtration rate in the preterm infant. Pediatr Res 1994 Nov; 36 (5): 578-81
11. Leake RD, Trygstad CW, Oh W. Inulin clearance in the newborn infant: relationship to gestational and postnatal age. Pediatr Res 1976 Aug; 10 (8): 759-62
12. van den Anker JN, Schoemaker RC, Hop WC, et al. Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age. Clin Pharmacol Ther 1995 Dec; 58 (6): 650-9
13. Fawer CL, Torrado A, Guignard JP. Maturation of renal function in full-term and premature neonates. Helv Paediatr Acta 1979 Feb; 34 (1): 11-21
14. Rosario MC, Thomson AH, Jodrell DI, et al. Population pharmacokinetics of gentamicin in patients with cancer. Br J Clin Pharmacol 1998 Sep; 46 (3): 229-36
15. Staatz CE, Byrne C, Thomson AH. Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery. Br J Clin Pharmacol 2006 Feb; 61 (2): 164-76
16. Kirkpatrick CM, Duffull SB, Begg EJ. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily. Br J Clin Pharmacol 1999 Jun; 47 (6): 637-43
17. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16 (1): 31-41
18. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 Mar 16; 130 (6): 461-70
19. Nolte S, Mueller B, Pringsheim W. Serum alpha 1-microglobulin and beta 2-microglobulin for the estimation of fetal glomerular renal function. Pediatr Nephrol 1991 Sep; 5 (5): 573-7
20. Bokenkamp A, Domanetzki M, Zinck R, et al. Cystatin C: a new marker of glomerular filtration rate inchildren independent ofage and height. Pediatrics 1998 May; 101 (5): 875-81
21. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function: a review. Clin Chem Lab Med 1999 Apr; 37 (4): 389-95
22. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 2002 May; 48 (5): 699-707
23. Grubb A, Nyman U, Bjork J, et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 2005 Aug; 51 (8): 1420-31
24. Bokenkamp A, Dieterich C, Dressler F, et al. Fetal serum concentrations of cystatin C and beta2-microglobulin as predictors of postnatal kidney function. Am J Obstet Gynecol 2001 Aug; 185 (2): 468-75
25. Lanao JM, Calvo MV, Mesa JA, et al. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates. J Antimicrob Chemother 2004 Jul; 54 (1): 193-8
26. Thomson AH, Way S, Bryson SM, et al. Population pharmacokinetics of gentamicin in neonates. Dev Pharmacol Ther 1988; 11 (3): 173-9
27. Garcia B, Barcia E, Perez F, et al. Population pharmacokinetics of gentamicin in premature newborns. J Antimicrob Chemother 2006 Aug; 58 (2): 372-9
28. Weber W, Kewitz G, Rost KL, et al. Population kinetics of gentamicin in neonates. Eur J Clin Pharmacol 1993; 44 Suppl. 1: S23-5
29. Rocha MJ, Almeida AM, Afonso E, et al. The kinetic profile of gentamicin in premature neonates. J Pharm Pharmacol 2000 Sep; 52 (9): 1091-7
30. Jensen PD, Edgren BE, Brundage RC. Population pharmacokinetics of gentamicin in neonates usinganonlinear, mixed-effects model. Pharmacotherapy 1992; 12 (3): 178-82
31. Botha JH, du Preez MJ, Adhikari M. Population pharmacokinetics of gentamicin in South African newborns. Eur J Clin Pharmacol 2003 Dec; 59 (10): 755-9
32. Schentag JJ, Jusko WJ. Renal clearance and tissue accumulationofgentamicin. Clin Pharmacol Ther 1977 Sep; 22 (3): 364-70
33. Laskin OL, Longstreth JA, Smith CR, et al. Netilmicin and gentamicin multi-dose kinetics in normal subjects. Clin Pharmacol Ther 1983 Nov; 34 (5): 644-50
34. Heimann G. Renal toxicity of aminoglycosides in the neonatal period. Pediatr Pharmacol (New York) 1983; 3 (3-4): 251-7
35. Larsson A, Malm J, Grubb A, et al. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C valuesin mg/L. Scand J Clin Lab Invest 2004; 64 (1): 25-30
36. Flodin M, Jonsson AS, Hansson LO, et al. Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L. Scand J Clin Lab Invest 2007; 67 (5): 560-7
37. Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008; 48: 303-32
38. Lindbom L, Pihlgren P, Jonsson EN. PsN-Toolkit: a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed 2005 Sep; 79 (3): 241-57
39. Wilkins JJ, Karlsson MO, Jonsson EN. Patterns and power for the visual predictive check [abstract no 1029]. Annual Meeting of the Population Approach Group in Europe; 2006 Jun 14-16, Brugge [online]. Available from URL: http://www.page-meeting.org [Accessed 2009 Feb 20]
40. Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981 Aug; 9 (4): 503-12
41. Beal SL, Sheiner LB, Boeckmann AJ. NONMEM users guides. Ellicott City (MD): Icon Development Solutions, 1989-2006
42. Jonsson EN, Karlsson MO. Xpose: an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 1999; 58: 51-64
43. Karlsson MO, Savic RM. Diagnosing model diagnostics. Clin Pharmacol Ther 2007 Jul; 82 (1): 17-20
44. West GB, Brown JH, Enquist BJ. The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science 1999 Jun 4; 284 (5420): 1677-9
45. Anderson BJ, Allegaert K, Holford NH. Population clinical pharmacology of children: modelling covariate effects. Eur J Pediatr 2006 Dec; 165 (12): 819-29
46. Holford NH. A size standard for pharmacokinetics. Clin Pharmacokinet 1996 May; 30 (5): 329-32
47. DiCenzo R, Forrest A, Slish JC, et al. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates. Pharmacotherapy 2003 May; 23 (5): 585-91
48. Anderson BJ, Allegaert K, Van den Anker JN, et al. Vancomycin pharmaco-kinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol 2007 Jan; 63 (1): 75-84
49. Kimura T, Sunakawa K, Matsuura N, et al. Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates. Antimicrob Agents Chemother 2004 Apr; 48 (4): 1159-67
50. Allegaert K, Anderson BJ, van den Anker JN, et al. Renal drug clearance in preterm neonates: relation to prenatal growth. Ther Drug Monit 2007 Jun; 29 (3): 284-91
51. Rhodin MM, Anderson BJ, Peters AM, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 2009 Jan; 24 (1): 67-76
52. Harmoinen A, Ylinen E, Ala-Houhala M, et al. Reference intervals for cystatin C in pre- and full-term infants and children. Pediatr Nephrol 2000 Nov; 15 (1-2): 105-8
53. Treiber M, Pecovnik-Balon B, Gorenjak M. Cystatin C versus creatinine as a marker of glomerular filtration rate in the newborn. Wien Klin Wochenschr 2006; 118 Suppl. 2: 66-70
54. Stolk LM, Degraeuwe PL, Nieman FH, et al. Population pharmacokinetics and relationship between demographic and clinical variables and pharmaco-kinetics of gentamicin in neonates. Ther Drug Monit 2002 Aug; 24 (4): 527-31
55. Young TE, Mangum OB. Neofax: a manual of drugs used in neonatal care. 20th ed. Montvale (NJ): Thomson Healthcare, 2007: 40-41